VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Cash and short-term investments, 2025
- $6.6B
- YoY, 2025
- +8.0%
- 5-year CAGR
- −0.2%
- 10-year CAGR
- +20.3%
Cash and short-term investments
Cash and short-term investments by fiscal year
| Period | Cash | YoY |
|---|---|---|
| 2025 | $6.6B | +8.0% |
| 2024 | $6.1B | −45.5% |
| 2023 | $11.2B | +4.1% |
| 2022 | $10.8B | +43.2% |
| 2021 | $7.5B | +13.0% |
| 2020 | $6.7B | +74.9% |
| 2019 | $3.8B | +20.2% |
| 2018 | $3.2B | +51.7% |
| 2017 | $2.1B | +45.6% |
| 2016 | $1.4B | +37.6% |
| 2015 | $1.0B | −24.8% |
| 2014 | $1.4B | −5.3% |
| 2013 | $1.5B | +10.9% |
| 2012 | $1.3B | +36.4% |
| 2011 | $969M | −6.1% |
| 2010 | $1.0B | −19.7% |
| 2009 | $1.3B | +230.2% |
| 2008 | $389M | — |